DEUTSCHE BANK AG\ - EVOFEM BIOSCIENCES INC ownership

EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 38 filers reported holding EVOFEM BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of EVOFEM BIOSCIENCES INC
ValueSharesWeighting
Q2 2021$11,000
-88.0%
9,639
-81.6%
0.00%
Q1 2021$92,000
-32.8%
52,516
-8.2%
0.00%
Q4 2020$137,000
+41.2%
57,183
+39.9%
0.00%
Q3 2020$97,000
+42.6%
40,870
+70.1%
0.00%
Q2 2020$68,000
+172.0%
24,022
+409.9%
0.00%
Q1 2020$25,000
-37.5%
4,711
-31.4%
0.00%
Q4 2019$40,000
+122.2%
6,871
+70.4%
0.00%
Q3 2019$18,000
-73.9%
4,033
-62.1%
0.00%
Q2 2019$69,00010,6470.00%
Other shareholders
EVOFEM BIOSCIENCES INC shareholders Q2 2019
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 1,100,000$812,0000.27%
Westside Investment Management, Inc. 10,000$7,230,0000.02%
Baker Brothers Advisors 2,697,110$1,992,0000.01%
Bedel Financial Consulting, Inc. 22,500$17,0000.01%
Congress Park Capital LLC 14,500$11,0000.01%
Callan Capital, LLC 50,000$37,0000.01%
FULLER & THALER ASSET MANAGEMENT, INC. 1,079,860$798,0000.01%
GSA CAPITAL PARTNERS LLP 60,381$45,0000.01%
Platform Technology Partners 13,000$10,0000.01%
JB CAPITAL PARTNERS LP 23,184$17,0000.00%
View complete list of EVOFEM BIOSCIENCES INC shareholders